文献速递乳腺MR

表观扩散系数作为评估浸润性导管乳腺癌增殖潜能的影像生物标志物的效用

Utility of apparent diffusion coefficient as an imaging biomarker for assessing the proliferative potential of invasive ductal breast cancer.
PubMed 文献 · Clin Radiol · 2017-12-19

80例经病理证实的浸润性导管乳腺癌患者在3-T系统上行b值0和800 s/mm²的扩散加权成像,从全肿瘤体积ADC图记录ADCmean、ADCmedian、ADCmin、ADCmax和ΔADC(ADCmax-ADCmin),并与Ki-67标记指数(≥14%为高增殖,<14%为低增殖)相关。ADCmin、ADCmax和ΔADC与Ki-67 LI显著相关,ADCmean和ADCmedian无显著相关;ΔADC在全肿瘤人群和luminal/HER2阴性组中鉴别高、低增殖组的ROC曲线下面积最高。ΔADC可能作为预测浸润性导管乳腺癌Ki-67增殖状态的有前景的影像生物标志物。

要点

  • ΔADC与Ki-67 LI相关性最强,全肿瘤r=0.551,luminal/HER2阴性组r=0.639。
  • ΔADC鉴别高、低增殖组AUC全肿瘤0.825,luminal/HER2阴性组0.844。
  • ADCmean和ADCmedian与Ki-67 LI无显著相关(均p>0.05)。

核心结论

  • ΔADC可能作为预测浸润性导管乳腺癌Ki-67增殖状态的有前景的影像生物标志物。

研究设计与样本

  • 80例经病理证实的浸润性导管乳腺癌患者(80个病灶)在3-T系统上行b值0和800 s/mm²的扩散加权成像,从全肿瘤体积ADC图记录ADC指标并与Ki-67 LI相关。

诊断标准与关键数值

  • Ki-67染色≥14%为高增殖,<14%为低增殖;ADCmin、ADCmax、ΔADC与Ki-67 LI显著相关(全肿瘤r=-0.311、0.436、0.551;luminal/HER2阴性组r=-0.437、0.512、0.639;均p<0.01)。

临床应用与阅片要点

  • ΔADC鉴别高、低增殖组AUC全肿瘤0.825(95%CI 0.724, 0.901),luminal/HER2阴性组0.844(95%CI 0.692, 0.940)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To determine the clinical utility of apparent diffusion coefficient (ADC) metrics for the non-invasive assessment of tumour proliferation indicated by Ki-67 labelling index (LI) in invasive ductal breast cancer.

MATERIALS AND METHODS: Eighty patients with 80 histopathologically proven invasive ductal breast cancers underwent diffusion-weighted imaging with b-values of 0 and 800 s/mm2 at a 3-T system. ADC metrics including ADCmean, ADCmedian, ADCmin, ADCmax, and ΔADC (ADCmax-ADCmin) were recorded from the entire tumour volume on ADC maps, and correlated with the Ki-67 LI. Ki-67 staining of ≥14% was considered to indicate high proliferation and <14% was considered to indicate low proliferation.

RESULTS: ADCmin, ADCmax, and ΔADC showed significant correlations with the Ki-67 LI (for all tumours, r=-0.311, 0.436, and 0.551, respectively; for luminal/human epidermal growth factor receptor 2 (HER2)-negative group, r=-0.437, 0.512, and 0.639, respectively; all p<0.01), whereas ADCmean and ADCmedian showed no significant correlation (both p>0.05). Receiver operating characteristic (ROC) curve analysis for the differentiation of high- from low-proliferation groups showed that ΔADC yielded the highest area under the ROC curve for the whole tumour population (0.825; 95% confidence interval [CI]: 0.724, 0.901), as well as for the luminal/HER2-negative group (0.844; 95% CI: 0.692, 0.940).

CONCLUSION: ΔADC may serve as a promising imaging biomarker for the prediction of Ki-67 proliferation status in invasive ductal breast cancer.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Zhuang Z, Zhang Q, Zhang D, et al. Utility of apparent diffusion coefficient as an imaging biomarker for assessing the proliferative potential of invasive ductal breast cancer. Clin Radiol. 2017. PMID: 29273228. doi:10.1016/j.crad.2017.11.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。